by US Medical Innovations | Oct 6, 2021 | 2021 Press Release, Press Release
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological...
by US Medical Innovations | Sep 9, 2021 | 2021 Press Release, Press Release
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S....
by US Medical Innovations | Sep 2, 2021 | 2021 Press Release, Press Release
JCRI Discovers the Mechanism using Canady Helios™ Cold Plasma to Induce Cell Death in Breast Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), in collaboration with...
by US Medical Innovations | May 5, 2021 | 2021 Press Release, Press Release
USMI Developing the First Surgical Robot for Cancer Surgery TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI) announced today that it is developing the first robotic delivery system used for cancer surgery. The new Canady Surgical System...
by US Medical Innovations | Apr 28, 2021 | 2021 Press Release, Press Release
JCRI-ABTS and USMI Successfully Use Canady Helios™ Cold Plasma in Combination with FOLFIRINOX for the Treatment of Cholangiocarcinoma TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological Sciences...
by US Medical Innovations | Apr 20, 2021 | 2021 Press Release, Press Release
JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer TAKOMA PARK, Md.–(BUSINESS WIRE)–The Jerome Canady Research Institute for Advanced Biological and Technological...
